Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on June 1, 2026

8 hours ago

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

Indeterminate GlobeNewswire

8 hours ago

MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026

Indeterminate GlobeNewswire

8 hours ago

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Indeterminate GlobeNewswire

8 hours ago

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Indeterminate GlobeNewswire

8 hours ago

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

8 hours ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Indeterminate GlobeNewswire

8 hours ago

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Indeterminate GlobeNewswire

8 hours ago

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

Indeterminate GlobeNewswire

8 hours ago

Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026

Indeterminate GlobeNewswire

9 hours ago

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

Indeterminate GlobeNewswire

9 hours ago

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Indeterminate GlobeNewswire

9 hours ago

Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

9 hours ago

Vireo Growth Inc. Announces Share Consolidation

Indeterminate GlobeNewswire

9 hours ago

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Indeterminate GlobeNewswire

9 hours ago

Cognition Therapeutics Participating in Upcoming Investor Conferences

Indeterminate GlobeNewswire

9 hours ago

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

Indeterminate GlobeNewswire

9 hours ago

BriaCell Presents Positive Clinical Data at ASCO 2026

Indeterminate GlobeNewswire

9 hours ago

TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics

Indeterminate GlobeNewswire

9 hours ago

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Indeterminate GlobeNewswire

9 hours ago

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Indeterminate GlobeNewswire